SCHEMBL19681163

SCHEMBL19681163

COC(=O)c1[nH]c2ccc(Cl)cc2c1NC(=O)CN1CCC(Cc2ccccc2)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 19/20 0.72
HSD17B10 Q99714 14/20 0.72
TSHR P16473 3/20 0.72
HPGD P15428 11/20 0.69
MAPT P10636 9/20 0.69
MAPK1 P28482 8/20 0.69
SMN1; SMN2 Q16637 4/20 0.69
LMNA P02545 3/20 0.69
ALDH1A1 P00352 13/20 0.65
USP2 O75604 4/20 0.65
CASP7 P55210 1/20 0.65
NPSR1 Q6W5P4 4/20 0.64
HTT P42858 5/20 0.60
KMT2A Q03164 3/20 0.59
MEN1 O00255 2/20 0.59
APOBEC3A P31941 1/20 0.59
APOBEC3G Q9HC16 1/20 0.59
POLB P06746 3/20 0.58
NPC1 O15118 1/20 0.55
GAA P10253 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19681044 0.90 KDM4E (0.77) KDM4EHSD17B10TSHRHPGDMAPT
SCHEMBL19680991 0.90 KDM4E (0.71) KDM4EHSD17B10TSHRHPGDMAPT
SCHEMBL18825288 0.88 KDM4E (0.82) KDM4EHSD17B10TSHRHPGDMAPT
SCHEMBL30585535 0.88 KDM4E (0.82) KDM4EHSD17B10TSHRHPGDMAPT
SCHEMBL19681157 0.88 KDM4E (0.74) KDM4EHSD17B10TSHRHPGDMAPT
SCHEMBL19681153 0.86 KDM4E (0.56) KDM4EHSD17B10TSHRHPGDMAPT
SCHEMBL19680989 0.84 KDM4E (0.81) KDM4EHSD17B10TSHRHPGDMAPT
SCHEMBL19681161 0.81 KDM4E (0.57) KDM4EHSD17B10TSHRHPGDMAPT
SCHEMBL19680983 0.77 KDM4E (0.74) KDM4EHSD17B10TSHRHPGDMAPT
SCHEMBL19681211 0.76 KDM4E (0.81) KDM4EHSD17B10TSHRHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294214-B2 Positive allosteric modulators of human melanocortin-4 receptor VANDERBILT UNIVERSITY (US) 2019-05-21 US disclosed
US-20170349571-A1 POSITIVE ALLOSTERIC MODULATORS OF HUMAN MELANOCORTIN-4 RECEPTOR NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294214-B2 Positive allosteric modulators of human melanocortin-4 receptor MC4R, MC1R, MC3R KDM4E 932/4885HSD17B10 4416/4885TSHR 34/4885
US-20170349571-A1 POSITIVE ALLOSTERIC MODULATORS OF HUMAN MELANOCORTIN-4 RECEPTOR MC4R, MC1R, MC3R KDM4E 932/4885HSD17B10 4416/4885TSHR 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.